Progentec Diagnostics

company

About

Progentec is engaged in state of the art diagnostic interventions in therapeutic areas with a high level of unmet need.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$5M
Industries
Biotechnology,Health Care,Health Diagnostics,Medical,Therapeutics
Founded date
Jul 21, 2015
Number Of Employee
1 - 10
Operating Status
Active

Progentec Diagnostics was set up to explore and commercialize state of the art diagnostic interventions in therapeutic areas with a high level of unmet need. The company is collaborating with a number of research institutions and individuals around the world engaged in bringing the latest technological innovations to the field of diagnostics. The commitment to this cause is firmly rooted in our belief that better diagnostics would not only help in better and less costly management of diseases, but also help tremendously in reducing the incidence of diseases through early screening and detection.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$5M
Progentec Diagnostics has raised a total of $5M in funding over 2 rounds. Their latest funding was raised on Jan 9, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 9, 2020 Series A $5M 1 Plains Venture Partners Detail
Nov 2, 2018 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Progentec Diagnostics is funded by 2 investors. Plains Venture Partners and NMC Lifesciences are the most recent investors.
Investor Name Lead Investor Funding Round
Plains Venture Partners Yes Series A
NMC Lifesciences Series Unknown